======= EPHA7 ======= == Gene Information == * **Official Symbol**: EPHA7 * **Official Name**: EPH receptor A7 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2045|2045]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q15375|Q15375]] * **Interactions**: [[https://thebiogrid.org/search.php?search=EPHA7&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EPHA7|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602190|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. Increased expression of this gene is associated with multiple forms of carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]. * **UniProt Summary**: N/A |Pkinase| |GCC2 GCC3| |fn3| |Pkinase Tyr| |Ephrin lbd| |SAM 2| |SAM 1| |branching morphogenesis of a nerve| |GPI-linked ephrin receptor activity| |negative regulation of synapse assembly| |negative regulation of collateral sprouting| |axon guidance receptor activity| |nephric duct morphogenesis| |nephric duct development| |transmembrane-ephrin receptor activity| |retinal ganglion cell axon guidance| |regulation of collateral sprouting| |negative regulation of synapse organization| |chemorepellent activity| |ephrin receptor binding| |hippocampal mossy fiber to CA3 synapse| |negative chemotaxis| |regulation of protein autophosphorylation| |integral component of postsynaptic density membrane| |positive regulation of neuron apoptotic process| |transmembrane receptor protein tyrosine kinase activity| |negative regulation of axonogenesis| |neuromuscular junction| |Schaffer collateral - CA1 synapse| |ephrin receptor signaling pathway| |protein tyrosine kinase activity| |positive regulation of neuron death| |regulation of postsynapse organization| |negative regulation of cell morphogenesis involved in differentiation| |negative regulation of developmental growth| |regulation of synapse assembly| |regulation of extent of cell growth| |kidney epithelium development| |peptidyl-tyrosine phosphorylation| |peptidyl-tyrosine modification| |negative regulation of neuron projection development| |morphogenesis of a branching structure| |regulation of cell size| |negative regulation of cell projection organization| |negative regulation of cell growth| |regulation of axonogenesis| |receptor complex| |regulation of neuron apoptotic process| |regulation of cysteine-type endopeptidase activity involved in apoptotic process| |regulation of synapse organization| |negative regulation of neuron differentiation| |regulation of synapse structure or activity| |regulation of cysteine-type endopeptidase activity| |negative regulation of growth| |regulation of peptidyl-tyrosine phosphorylation| |axon guidance| |neuron projection guidance| |kidney development| |renal system development| |negative regulation of neurogenesis| |regulation of ERK1 and ERK2 cascade| |regulation of cell morphogenesis involved in differentiation| |epithelial tube morphogenesis| |regulation of neuron death| |negative regulation of nervous system development| |urogenital system development| |neuron projection| |regulation of developmental growth| |negative regulation of cell development| |glutamatergic synapse| |axonogenesis| |neuronal cell body| |regulation of cellular component size| |regulation of cell-cell adhesion| |axon development| |regulation of endopeptidase activity| |regulation of cell growth| |dendrite| |morphogenesis of an epithelium| |cell morphogenesis involved in neuron differentiation| |regulation of peptidase activity| |neuron projection morphogenesis| |plasma membrane bounded cell projection morphogenesis| |cell projection morphogenesis| |regulation of cell morphogenesis| |regulation of neuron projection development| |transmembrane receptor protein tyrosine kinase signaling pathway| |regulation of anatomical structure size| |cell part morphogenesis| |chemotaxis| |taxis| |cell morphogenesis involved in differentiation| |tissue morphogenesis| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |tube morphogenesis| |regulation of neuron differentiation| |neuron projection development| |regulation of growth| |regulation of cell adhesion| |regulation of plasma membrane bounded cell projection organization| |positive regulation of cell death| |negative regulation of cellular component organization| |regulation of cell projection organization| |negative regulation of cell differentiation| |enzyme linked receptor protein signaling pathway| |cell morphogenesis| |regulation of proteolysis| |brain development| |regulation of MAPK cascade| |head development| |neuron development| |regulation of neurogenesis| |cellular component morphogenesis| |tube development| |peptidyl-amino acid modification| |apoptotic process| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |regulation of cellular component biogenesis| |protein phosphorylation| |central nervous system development| |neuron differentiation| |positive regulation of protein phosphorylation| |programmed cell death| |positive regulation of phosphorylation| |regulation of anatomical structure morphogenesis| |cell death| |epithelium development| |plasma membrane bounded cell projection organization| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |cell projection organization| |negative regulation of multicellular organismal process| |positive regulation of protein modification process| |regulation of hydrolase activity| |phosphorylation| |locomotion| |integral component of plasma membrane| |regulation of protein phosphorylation| |ATP binding| |generation of neurons| |regulation of apoptotic process| |movement of cell or subcellular component| |regulation of programmed cell death| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |neurogenesis| |cell development| |regulation of cell death| |positive regulation of protein metabolic process| |tissue development| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of cell differentiation| |regulation of intracellular signal transduction| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|1.99| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 14680 * **Expression level (log2 read counts)**: -1.95 {{:chemogenomics:nalm6 dist.png?nolink |}}